Sales Force Downsizing By Big Pharma Means Small/Mid-Tier Boom, CSOs Say
Executive Summary
Sales force restructuring among large pharmaceutical companies is helping to drive contract sales agreements with small and mid-tier companies, contract sales organizations say
You may also be interested in...
Waiting For Pfizer: GSK Will Cut Sales Force Should Pfizer Act First
GlaxoSmithKline will reduce the size of its sales force and reinvest those expenditures in research and development should Pfizer decide to downsize its sales team, GSK CEO J.P. Garnier said
Industry Cost Structure Must Change, But Will Not Start At AstraZeneca – CEO
AstraZeneca CEO Tom McKillop called on the pharmaceutical industry to reduce the costs associated with selling and marketing drugs, but does not believe his company will be the catalyst for change
Bristol Outsourcing Of Cefzil, Tequin To Ventiv May Be New Model For CSOs
Bristol Myers-Squibb's sales agreement with Ventiv for the promotion of the antibiotics Cefzil and Tequin may be a new model for using contract sales organizations in an environment of downsizing